Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnelly J, Verhamme P, Jacobsen AF, Ganzevoort W, Prins M, Beyer-Westendorf J, DeSancho M, Konstantinides S, Pabinger I, Rodger M, Decousus H, Middeldorp S. Bleker SM, et al. Among authors: desancho m. Thromb Res. 2016 Aug;144:62-8. doi: 10.1016/j.thromres.2016.06.001. Epub 2016 Jun 3. Thromb Res. 2016. PMID: 27289488 Clinical Trial.
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.
Schulman S, Zondag M, Linkins L, Pasca S, Cheung YW, de Sancho M, Gallus A, Lecumberri R, Molnar S, Ageno W, Le Gal G, Falanga A, Hulegårdh E, Ranta S, Kamphuisen P, Debourdeau P, Rigamonti V, Ortel TL, Lee A. Schulman S, et al. J Thromb Haemost. 2015 Jun;13(6):1010-8. doi: 10.1111/jth.12955. Epub 2015 May 9. J Thromb Haemost. 2015. PMID: 25851122 Free article.
ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
de Jong PG, Quenby S, Bloemenkamp KW, Braams-Lisman BA, de Bruin JP, Coomarasamy A, David M, DeSancho MT, van der Heijden OW, Hoek A, Hutten BA, Jochmans K, Koks CA, Kuchenbecker WK, Mol BW, Torrance HL, Scheepers HC, Stephenson MD, Verhoeve HR, Visser J, de Vries JI, Goddijn M, Middeldorp S. de Jong PG, et al. Among authors: desancho mt. Trials. 2015 May 7;16:208. doi: 10.1186/s13063-015-0719-9. Trials. 2015. PMID: 25947329 Free PMC article. Clinical Trial.
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Raskob GE, et al. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Free article. Clinical Trial.
Transition of care for patients with venous thromboembolism: Rationale, design and implementation of a quality intervention project conducted at American Thrombosis and Hemostasis Network (ATHN) affiliated sites.
Jaffray J, Rajpurkar M, Sharathkumar A, Patel K, Munn J, Cheng D, McCarthy E, DeSancho M. Jaffray J, et al. Among authors: desancho m. Thromb Res. 2018 Mar;163:146-152. doi: 10.1016/j.thromres.2018.01.043. Epub 2018 Feb 2. Thromb Res. 2018. PMID: 29407627
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC.
Tardy B, Chalayer E, Kamphuisen PW, Ni Ainle F, Verhamme P, Varlet MN, Chauleur C, Rodger M, Merah A, Buchmuller A, Bistervels I, De Sancho MT, Middeldorp S, Bertoletti L; SSC Subcommittee on Control of Anticoagulation of the ISTH. Tardy B, et al. J Thromb Haemost. 2019 Nov;17(11):1979-1988. doi: 10.1111/jth.14576. Epub 2019 Aug 12. J Thromb Haemost. 2019. PMID: 31402557 Free article. No abstract available.
77 results